Leaders of China Biotechnology Co., Ltd. visited ToCell to provide guidance
Release Time:
2020-06-03
On the morning of May 27, 2020, China Biologic's President Wu Yonglin, Vice President Li Xiangrong, Planning and Development Director Li Li, Investment Management Director Teng Yubei, and Production Management Director Yang Ming visited CNBG ToCell
On the morning of May 27, 2020, China Biologic's President Wu Yonglin, Vice President Li Xiangrong, Planning and Development Director Li Li, Investment Management Director Teng Yubei, and Production Management Director Yang Ming visited CNBG ToCell Bio-Suzhou Company to provide guidance.On the morning of May 27, 2020, China Biologic's President Wu Yonglin, Vice President Li Xiangrong, Planning and Development Director Li Li, Investment Management Director Teng Yubei, and Production Management Director Yang Ming visited CNBG ToCell Bio-Suzhou Company to provide guidance.
The leaders of CNBG listened to the company's history, company positioning, operations and R&D reports, and visited the ToCell plant. The leaders of CNBG fully affirmed ToCell's work. ToCell has entered a new stage of development. The leaders of CNBG hope that we will uphold the concept of "innovation, progress, stability and pragmatism", make good development plans at the height of national strategy, and achieve high-quality development of the company in the fields of veterinary and human biology, and continue to contribute to the Chinese biopharmaceutical industry.
More News
Official account
Wuxi Address: 699 Zhide Avenue, Xinwu District, Wuxi City
Suzhou Address: Entrance A, 1F, Zhanhua Science and Technology Building, No. 8 Pangyang Road, Wujiang District, Suzhou City, Jiangsu Province
Copyright：© 2025 CNBG ToCell (Wuxi) Biotechnology Co., Ltd. Powered by：www.300.cn SEO